Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABBOTT LABORATORIESABT · Entity 2314 | Senior Vice President | March 26, 2015 | March 27, 2015 |
| AMYRIS, INC.AMRS · Entity 91367 | Director | August 29, 2023 | September 20, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABBOTT LABORATORIES
Report date March 26, 2015 · Filed March 27, 2015
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common shares without par valueSEC Table I · non-derivative | Direct | 95,719 |
Ending reported balance
After 2015-03-26 transaction · row 6
6 source rows · reconciled sequenceRow 1 · 2015-03-26 · Exercise / conversion · Acquired 10,100 · Balance 99,702 Row 2 · 2015-03-26 · Exercise / conversion · Acquired 8,500 · Balance 108,202 Row 3 · 2015-03-26 · Sale · Disposed 5,068 · Balance 103,134 Row 4 · 2015-03-26 · Sale · Disposed 800 · Balance 102,334 Row 5 · 2015-03-26 · Sale · Disposed 6,515 · Balance 95,819 Row 6 · 2015-03-26 · Sale · Disposed 100 · Balance 95,719 |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $23.56 · Expires 2015-06-29 | Direct | 0 |
Reported balance
After 2015-03-26 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2015-03-26 · Exercise / conversion · Disposed 10,100 · Balance 0 F1: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $21.22 · Expires 2016-02-16 | Direct | 0 |
Reported balance
After 2015-03-26 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2015-03-26 · Exercise / conversion · Disposed 8,500 · Balance 0 F1: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. |
Filing footnotes · ownership attribution and instrument terms
F1: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.
AMYRIS, INC.
Report date August 29, 2023 · Filed September 20, 2023
This filing explicitly reported no securities owned.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 26, 2015 Filed Mar 27, 2015 21:10 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 8,500 | $0.00 Strike: $21.22 | $0.00 |
DisclosureSEC source: 0001179110-15-005495 · edgar.xml · derivative · entry 8 White J. Scott · CIK 0001479543 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 8,500 shares Expires 2016-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 26, 2015 Filed Mar 27, 2015 21:10 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 10,100 | $0.00 Strike: $23.56 | $0.00 |
DisclosureSEC source: 0001179110-15-005495 · edgar.xml · derivative · entry 7 White J. Scott · CIK 0001479543 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 10,100 shares Expires 2015-06-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 26, 2015 Filed Mar 27, 2015 21:10 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $46.69 | $4,668.50 |
DisclosureSEC source: 0001179110-15-005495 · edgar.xml · nonDerivative · entry 6 White J. Scott · CIK 0001479543 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,719 Read SEC document |
| March 26, 2015 Filed Mar 27, 2015 21:10 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 6,515 | $46.68 | $304,126.72 |
DisclosureSEC source: 0001179110-15-005495 · edgar.xml · nonDerivative · entry 5 White J. Scott · CIK 0001479543 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,819 Read SEC document |
| March 26, 2015 Filed Mar 27, 2015 21:10 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 800 | $46.68 | $37,344.00 |
DisclosureSEC source: 0001179110-15-005495 · edgar.xml · nonDerivative · entry 4 White J. Scott · CIK 0001479543 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,334 Read SEC document |
| March 26, 2015 Filed Mar 27, 2015 21:10 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 5,068 | $46.67 | $236,523.56 |
DisclosureSEC source: 0001179110-15-005495 · edgar.xml · nonDerivative · entry 3 White J. Scott · CIK 0001479543 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,134 Read SEC document |
| March 26, 2015 Filed Mar 27, 2015 21:10 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 8,500 | $21.22 | $180,364.90 |
DisclosureSEC source: 0001179110-15-005495 · edgar.xml · nonDerivative · entry 2 White J. Scott · CIK 0001479543 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,202 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 26, 2015 Filed Mar 27, 2015 21:10 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 10,100 | $23.56 | $237,999.43 |
DisclosureSEC source: 0001179110-15-005495 · edgar.xml · nonDerivative · entry 1 White J. Scott · CIK 0001479543 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,702 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2015 Filed Mar 3, 2015 22:21 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 8,144 | $47.61 | $387,735.84 |
DisclosureSEC source: 0001179110-15-004051 · edgar.xml · nonDerivative · entry 1 White J. Scott · CIK 0001479543 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,602 Read SEC document |
| February 20, 2015 Filed Feb 24, 2015 22:45 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 121,064 | $0.00 Strike: $47.00 | $0.00 |
DisclosureSEC source: 0001179110-15-003333 · edgar.xml · derivative · entry 2 White J. Scott · CIK 0001479543 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,064 Underlying: Common shares · 121,064 shares Expires 2025-02-19 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 40,355 on 2/20/16, 40,354 on 2/20/17, and 40,355 on 2/20/18. Read SEC document |
| February 20, 2015 Filed Feb 24, 2015 22:45 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 17,180 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-003333 · edgar.xml · nonDerivative · entry 1 White J. Scott · CIK 0001479543 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,746 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 28, 2014 Filed Mar 4, 2014 22:10 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 10,477 | $39.79 | $416,879.83 |
DisclosureSEC source: 0001179110-14-004323 · edgar.xml · nonDerivative · entry 1 White J. Scott · CIK 0001479543 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,566 Read SEC document |
| February 21, 2014 Filed Feb 25, 2014 22:39 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 92,183 | $0.00 Strike: $39.12 | $0.00 |
DisclosureSEC source: 0001179110-14-003636 · edgar.xml · derivative · entry 2 White J. Scott · CIK 0001479543 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,183 Underlying: Common shares · 92,183 shares Expires 2024-02-20 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 30,728 on 2/21/2015, 30,727 on 2/21/2016, and 30,728 on 2/21/2017. Read SEC document |
| February 21, 2014 Filed Feb 25, 2014 22:39 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 15,057 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-14-003636 · edgar.xml · nonDerivative · entry 1 White J. Scott · CIK 0001479543 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,043 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 28, 2013 Filed Mar 2, 2013 00:47 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 11,520 | $34.26 | $394,675.20 |
DisclosureSEC source: 0001179110-13-003906 · edgar.xml · nonDerivative · entry 1 White J. Scott · CIK 0001479543 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,986 Read SEC document |
| February 19, 2013 Filed Feb 20, 2013 23:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 9,860 | $35.08 | $345,888.80 |
DisclosureSEC source: 0001179110-13-003171 · edgar.xml · nonDerivative · entry 2 White J. Scott · CIK 0001479543 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,506 Read SEC document |
| February 15, 2013 Filed Feb 20, 2013 23:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 133,500 | $0.00 Strike: $34.94 | $0.00 |
DisclosureSEC source: 0001179110-13-003171 · edgar.xml · derivative · entry 3 White J. Scott · CIK 0001479543 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,500 Underlying: Common shares · 133,500 shares Expires 2023-02-14 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 44,500 on 2/15/2014, 44,500 on 2/15/2015, and 44,500 on 2/15/2016. Read SEC document |
| February 15, 2013 Filed Feb 20, 2013 23:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 25,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-13-003171 · edgar.xml · nonDerivative · entry 1 White J. Scott · CIK 0001479543 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,366 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| April 24, 2012 Filed Apr 26, 2012 21:21 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $60.70 | $6,070.01 |
DisclosureSEC source: 0001179110-12-007224 · edgar.xml · nonDerivative · entry 5 White J. Scott · CIK 0001479543 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,666 Read SEC document |
| April 24, 2012 Filed Apr 26, 2012 21:21 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 700 | $60.70 | $42,490.00 |
DisclosureSEC source: 0001179110-12-007224 · edgar.xml · nonDerivative · entry 4 White J. Scott · CIK 0001479543 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,766 Read SEC document |
| April 24, 2012 Filed Apr 26, 2012 21:21 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $60.69 | $6,069.03 |
DisclosureSEC source: 0001179110-12-007224 · edgar.xml · nonDerivative · entry 3 White J. Scott · CIK 0001479543 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,466 Read SEC document |
| April 24, 2012 Filed Apr 26, 2012 21:21 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 3,833 | $60.69 | $232,624.77 |
DisclosureSEC source: 0001179110-12-007224 · edgar.xml · nonDerivative · entry 2 White J. Scott · CIK 0001479543 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,566 Read SEC document |
| April 24, 2012 Filed Apr 26, 2012 21:21 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 6,635 | $60.68 | $402,611.80 |
DisclosureSEC source: 0001179110-12-007224 · edgar.xml · nonDerivative · entry 1 White J. Scott · CIK 0001479543 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,399 Read SEC document |
| February 29, 2012 Filed Mar 2, 2012 22:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 6,051 | $57.04 | $345,149.04 |
DisclosureSEC source: 0001179110-12-004080 · edgar.xml · nonDerivative · entry 1 White J. Scott · CIK 0001479543 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,034 Read SEC document |
| February 20, 2012 Filed Feb 22, 2012 22:52 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 489 | $56.36 | $27,560.04 |
DisclosureSEC source: 0001179110-12-003233 · edgar.xml · nonDerivative · entry 2 White J. Scott · CIK 0001479543 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,085 Read SEC document |
| February 17, 2012 Filed Feb 22, 2012 22:52 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 44,000 | $0.00 Strike: $56.26 | $0.00 |
DisclosureSEC source: 0001179110-12-003233 · edgar.xml · derivative · entry 3 White J. Scott · CIK 0001479543 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,000 Underlying: Common shares · 44,000 shares Expires 2022-02-16 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 14,667 on 02/17/2013, 14,666 on 02/17/2014, and 14,667 on 02/17/2015. Read SEC document |
| February 17, 2012 Filed Feb 22, 2012 22:52 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 24,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-12-003233 · edgar.xml · nonDerivative · entry 1 White J. Scott · CIK 0001479543 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,574 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| December 14, 2011 Filed Dec 16, 2011 22:51 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,800 | $54.32 | $97,779.60 |
DisclosureSEC source: 0001179110-11-016817 · edgar.xml · nonDerivative · entry 2 White J. Scott · CIK 0001479543 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,174 Read SEC document |
| December 14, 2011 Filed Dec 16, 2011 22:51 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 5,697 | $54.32 | $309,466.74 |
DisclosureSEC source: 0001179110-11-016817 · edgar.xml · nonDerivative · entry 1 White J. Scott · CIK 0001479543 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,974 Read SEC document |
| February 28, 2011 Filed Mar 2, 2011 22:12 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 2,055 | $47.64 | $97,900.20 |
DisclosureSEC source: 0001179110-11-003915 · edgar.xml · nonDerivative · entry 1 White J. Scott · CIK 0001479543 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,671 Read SEC document |
| February 20, 2011 Filed Feb 23, 2011 22:53 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 496 | $46.88 | $23,252.48 |
DisclosureSEC source: 0001179110-11-003271 · edgar.xml · nonDerivative · entry 2 White J. Scott · CIK 0001479543 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,726 Read SEC document |
| February 18, 2011 Filed Feb 23, 2011 22:53 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 41,600 | $0.00 Strike: $46.60 | $0.00 |
DisclosureSEC source: 0001179110-11-003271 · edgar.xml · derivative · entry 3 White J. Scott · CIK 0001479543 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,600 Underlying: Common shares · 41,600 shares Expires 2021-02-17 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 13,867 on 02/18/2012, 13,866 on 02/18/2013, and 13,867 on 02/18/2014. Read SEC document |
| February 18, 2011 Filed Feb 23, 2011 22:53 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 29,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-11-003271 · edgar.xml · nonDerivative · entry 1 White J. Scott · CIK 0001479543 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,222 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 15, 2011 Filed Feb 17, 2011 22:01 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 173 | $45.98 | $7,954.54 |
DisclosureSEC source: 0001179110-11-002924 · edgar.xml · nonDerivative · entry 1 White J. Scott · CIK 0001479543 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,622 Read SEC document |
| February 20, 2010 Filed Feb 24, 2010 01:51 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 455 | $54.38 | $24,742.90 |
DisclosureSEC source: 0001179110-10-003601 · edgar.xml · nonDerivative · entry 3 White J. Scott · CIK 0001479543 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,795 Read SEC document |
| February 19, 2010 Filed Feb 24, 2010 01:51 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value · Derivative | 28,700 | $0.00 Strike: $54.50 | $0.00 |
DisclosureSEC source: 0001179110-10-003601 · edgar.xml · derivative · entry 4 White J. Scott · CIK 0001479543 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,700 Underlying: Common shares · 28,700 shares Expires 2020-02-18 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 9,567 on 2/19/2011, 9,566 on 2/19/2012, and 9,567 on 2/19/2013. Read SEC document |
| February 19, 2010 Filed Feb 24, 2010 01:51 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 21,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-10-003601 · edgar.xml · nonDerivative · entry 2 White J. Scott · CIK 0001479543 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,250 F2 · shares: These shares represent a retention award of restricted stock under the Abbott Laboratories 2009 Incentive Stock Program. The awards generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes. Read SEC document |
| February 19, 2010 Filed Feb 24, 2010 01:51 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 19,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-10-003601 · edgar.xml · nonDerivative · entry 1 White J. Scott · CIK 0001479543 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,250 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 16, 2010 Filed Feb 17, 2010 23:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 184 | $53.93 | $9,923.12 |
DisclosureSEC source: 0001179110-10-003045 · edgar.xml · nonDerivative · entry 2 White J. Scott · CIK 0001479543 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,650 Read SEC document |
| February 15, 2010 Filed Feb 17, 2010 23:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 173 | $53.93 | $9,329.89 |
DisclosureSEC source: 0001179110-10-003045 · edgar.xml · nonDerivative · entry 1 White J. Scott · CIK 0001479543 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,834 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.